Speech Processing Solutions Launches Philips SpeechLive Health, an AI Assistant Built for Modern Clinical Documentation
17.3.2026 15:00:00 CET | Business Wire | Press release
Philips SpeechLive Health AI Assistant uses healthcare-trained AI to convert clinical conversations into structured notes, helping clinicians reduce administrative burden
Speech Processing Solutions, the global leader in professional dictation and speech solutions sold under the Philips brand, today announced the upcoming April 2026 launch of Philips SpeechLive Health AI Assistant, an AI-powered clinical documentation assistant designed for healthcare professionals across multiple care settings. This solution reduces administrative burden, streamlines documentation, and improves provider and patient experiences.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260317743584/en/

Philips SpeechLive Health AI Assistant turns clinical conversations into structured documentation, helping reduce administrative workload and create more time for patient care.
Purpose-built for clinical documentation workflows
Clinical workload remains a major challenge across healthcare. In the U.S., AMIA’s 2024 TrendBurden survey found that 77% of healthcare professionals said documentation makes them work late or at home, while 74% said documentation impedes patient care1. In Europe, health systems are also under strain, with shortages of around 1.2 million doctors, nurses and midwives in the EU2. Philips SpeechLive Health AI Assistant is designed to address these pressures by reducing documentation effort, streamlining routine workflows, and enabling clinicians to spend more time on patient care.
SpeechLive Health captures clinical conversations in real time and converts them into structured documentation, including SOAP notes, visit summaries, and referral letters. By supporting clinicians during consultations, the solution helps streamline documentation while maintaining the accuracy and structure required for clinical records.
Unlike general-purpose AI models, SpeechLive Health uses a healthcare-trained large language model built by doctors specifically for medical environments. Built for clinical use, the system generates structured documentation that supports clinical workflows, coding and compliance requirements.
“For more than 70 years, Speech Processing Solutions has helped shape professional dictation and transcription in healthcare and has established a reputation as a leading partner in the medical market,” said Dr. Thomas Brauner, CEO of Speech Processing Solutions. “Philips SpeechLive Health marks the next step in that journey – building on the strong foundation of superior dictation hardware and leading software solutions combined. By adding this healthcare-trained AI assistant, we’re creating the next generation of an integrated solution that further reduces administrative burden, simplifies workflows and multiplies customer benefits, giving clinicians more time for patient care.”
AI designed for accuracy, compliance, and clinical trust
SpeechLive Health enables real-time documentation during visits, reducing the need for manual note-taking. In high-volume or conversation-heavy settings, the AI assistant reduces the time clinicians spend on documentation, allowing practitioners to stay present with their patients.
Built in line with SPS’s privacy-first strategy, SpeechLive Health has security and compliance at its core. The platform supports AES-256 encryption and aligns with major healthcare and data protection frameworks, including HIPAA and GDPR, while meeting internationally recognized standards such as ISO 27001. Clinicians retain control over stored audio files and editable documentation within the system.
Integrated software and hardware for clinical documentation
SpeechLive Health, used together with the new Philips SpeechMike Ambient Wearable AI Assistant for clinical environments, delivers the high level of audio capture quality required for successful clinical documentation. With a multi-microphone array and AI-based voice-filtering technology, the hands-free device captures clear speech from speakers and doctor-patient conversations, even in busy healthcare settings.
This supports accurate real-time documentation by complementing the SpeechLive Health platform, forming an end-to-end integrated solution designed to simplify clinical documentation workflows while maintaining the reliability and security required in healthcare.
Philips SpeechLive Health AI Assistant will be available starting in April 2026 through the global SpeechLive sales partner network.
Speech Processing Solutions (SPS):
Speech Processing Solutions (SPS) is the global leader in professional dictation and speech AI solutions, serving more than 4 million users in over 50 countries through a worldwide network of more than 1,000 partners. The company develops and markets industry-leading dictation and transcription solutions, documentation workflows powered by speech recognition, and award-winning dictation devices under the Philips brand. SPS’s mission is to empower every user to be more productive by simplifying their work with smart, voice-based solutions. Headquartered in Vienna, Austria, SPS has regional offices in Australia, Canada, Belgium, France, Germany, the United Kingdom, and the United States.
1https://amia.org/news-publications/amia-survey-underscores-impact-excessive-documentation-burden
2https://www.oecd.org/en/publications/health-at-a-glance-europe-2024_b3704e14-en/full-report.html
View source version on businesswire.com: https://www.businesswire.com/news/home/20260317743584/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Filippo Fagnani from Quanta System Receives the EAU Award for Significant Contribution to Endourology at ICE 202610.10.2026 18:09:00 CEST | Press release
Filippo Fagnani, Marketing & Scientific Director of Quanta System’s Surgical Division, has been honoured with the Award for Significant Contribution to Endourology at ICE26, the International Conference on Endourology organised by the EAU Endourology Section. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010101303/en/ Filippo Fagnani receiving the prize with Olivier Traxer and Professor Bhaskar Somani. The recognition celebrates more than two decades of professional commitment to laser technology and a career built around a clear ambition: to translate the needs of urologists into increasingly precise, flexible and useful technologies, with the ultimate goal of supporting patient safety and better surgical outcomes. “I have always believed that technology should make the surgeon’s work more precise, more flexible and, most importantly, safer for the patient. My goal has never been to develop technology for its own sake,
Emdoor Information Marks 18 Years of Rugged Computing Excellence with Vertically Integrated Capabilities10.10.2026 12:30:00 CEST | Press release
As industrial automation, smart manufacturing, and field operations increasingly depend on mission-critical mobile computing, global demand for reliable rugged tablets, rugged laptops, and rugged handhelds continues to accelerate. Emdoor Information, a publicly listed company on China’s A-share main board since 2023 and an 18-year veteran in rugged computing, has established itself as a rugged computing solutions provider for industrial customers worldwide. Founded in 2008, the company delivers sustained growth, world-class manufacturing, resilient supply chains, full-stack R&D, and comprehensive lifecycle services. Its rugged computing products and industrial customers now span North America, Latin America, Europe, and Asia-Pacific, serving sectors such as public utilities, intelligent manufacturing, warehouse management, transportation, energy industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010564561/en/ Rugged
Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press release
- Data on ALYFTREK in children ages 2 to 5 years demonstrate recovery of pancreatic function in some children –- Additional abstracts on clinical and real-world evidence on CFTR modulators also presented - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine p
Andersen Consulting udvider med TalentSmartEQ for at fremme lederskab og virksomhedstransformation9.10.2026 18:48:00 CEST | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for humankapital gennem en samarbejdsaftale med TalentSmartEQ, en San Diego-baseret virksomhed, der har fokus på at skabe praktiske, engagerende og handlingsorienterede læringsoplevelser med udgangspunkt i emotionel intelligens (EQ) og lederudvikling. I mere end to årtier har TalentSmartEQ arbejdet sammen med organisationer verden over med henblik på at udvikle ledelseskompetencer ved hjælp af emotionel intelligens og dermed styrke medarbejderengagement, teamwork og de samlede resultater. Virksomheden kombinerer forskningsbaserede metoder med praktiske læringsforløb, vurderinger, coaching og skræddersyede programmer, der skal omsætte opbygningen af emotionel intelligens til vedvarende ændringer i adfærden på arbejdspladsen. Som førende aktør i branchen samarbejder TalentSmartEQ med organisationer lige fra Fortune 500-virksomheder til offentlige myndigheder og privatejede virksomheder. "Organisationer stiller stadig større krav til dere
Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press release
Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation and reinforcing the security architecture behind each financial guarantee Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Sta
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom